Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression (Q83463350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

C A Derosa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S Shaheduzzaman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

V Srikantan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Z Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Y Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Seifert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

L Ravindranath

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

D Young

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Nau

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

A Dobi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

T Werner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

D G McLeod

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M T Vahey

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

I A Sesterhenn

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S Srivastava

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

G Petrovics

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

29 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

150-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2011.61

23 January 2020

exact match

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

A history of prostate cancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Epigenetic alterations in human prostate cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

The use of PCA3 in the diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Prostate cancer genomics: towards a new understanding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Molecular alterations in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Genomic instability--an evolving hallmark of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

30 years and a long way into p53 research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Androgen receptor structural and functional elements: role and regulation in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Targeting the PI3K/AKT pathway for the treatment of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

The polycomb group protein EZH2 is involved in progression of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

The role of SPINK1 in ETS rearrangement-negative prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

ETS gene fusions in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

SPARC: a matricellular regulator of tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Molecular pathway for cancer metastasis to bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

SPARC and tumor growth: where the seed meets the soil?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

SPARC (osteonectin/BM-40).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Regulatory networks: linking microarray data to systems biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Bioinformatics applications for pathway analysis of microarray data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Multievidence microarray mining

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Prostate cancer gene expression signature of patients with high body mass index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

JAGGED1 expression is associated with prostate cancer metastasis and recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

Molecular markers of prostate cancer outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.61

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22343836%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference